Ornithine aspartate is a commonly used medication in the treatment of liver diseases. If used improperly, it may cause nausea, vomiting, phlebitis, or even serious adverse reactions. Only by correctly understanding the misconceptions and using it in a standardized manner can we truly protect liver health. The most common, critical, and frequently misunderstood aspects of the use of ornithine aspartate in clinical practice include: 1. **Misconceptions about dosage and infusion rate**: Excessive dosage can lead to nausea, vomiting, abdominal distension, and headaches; in severe cases, it can cause arrhythmias. Rapid infusion significantly increases gastrointestinal reactions and the risk of phlebitis. 2. **Misconceptions about the appropriate population**: Patients with severe renal impairment should avoid using it as it can lead to toxicity. Individuals with allergic constitutions may experience rashes and itching, and in severe cases, anaphylactic shock. Healthy individuals using it as a “daily liver-protecting supplement” will not benefit and may increase the risk of adverse reactions. 3. **Misconceptions about administration and dosage form**: Injecting the solution without dilution can cause intense vascular irritation, pain, and phlebitis. The granular form should be taken on an empty stomach, which can worsen stomach discomfort; the correct approach is to take it after meals. 4. **Misconceptions about compatibility and combination with other drugs**: Mixing it with multiple medications in the same bottle (such as vitamin K1 or certain antibiotics) can cause the solution to become cloudy or precipitate, rendering it ineffective and increasing the risk of adverse reactions. The correct practice is to administer each medication separately and flush the tubing before and after. 5. **Misconceptions about monitoring and evaluation**: Failing to monitor blood ammonia, liver function, and kidney function during long-term use can result in unknown efficacy and hidden risks, potentially delaying treatment or leading to drug accumulation. Raising transaminase levels should not always be considered an indication for use, as it is not beneficial for all types of liver damage, especially those not related to high blood ammonia levels. 6. **Cognitive misconceptions**: There is a misconception that the more expensive or higher the dose, the better the effect. However, ornithine aspartate is only effective for conditions such as high blood ammonia, hepatic encephalopathy, and certain types of liver damage. Ignoring the drug instructions and guidelines and adjusting the treatment plan based on experience is incorrect; the proper approach is to strictly follow the “Guidelines for the Diagnosis and Treatment of Hepatic Encephalopathy” and the drug’s instructions. Ornithine aspartate is a prescription drug and should be used under the guidance of a doctor. Jingjing Pharmaceutical, a professional supplier of ornithine aspartate, reminds you that it should not be purchased and taken without medical supervision. Jingjing Pharmaceutical’s ornithine aspartate is produced using an enzymatic process, making it safer and more stable.